191 related articles for article (PubMed ID: 7333071)
1. [Evaluation of the bronchodilating effect of TH 1165 A and of salbutamol in patients with spastic obstructive ventilatory syndrome].
Iaia E; Cagnazzo R; Digilio VS; Scoditti A
Clin Ter; 1981 Dec; 99(5):499-505. PubMed ID: 7333071
[No Abstract] [Full Text] [Related]
2. [Fenoterol in the diagnosis and treatment of reversible bronchospasm].
Sevieri GP; Quartieri F; Del Bono N
Clin Ter; 1981 Dec; 99(6):615-22. PubMed ID: 7333073
[No Abstract] [Full Text] [Related]
3. Evaluation of the protective action of Salbutamol Polfa--aerosol in relation to histamine induced bronchospasm in patients with bronchial asthma, in comparison with the effect of Ventolin-Pliva, Astmopent-Polfa and Berotec-Boehringer.
Rozniecki J; Szmidt M; Grabski W; Gondorowicz K
Mater Med Pol; 1977; 9(4):331-5. PubMed ID: 599965
[No Abstract] [Full Text] [Related]
4. [Controlled clinical study of the effects of a single aerosol administration of a fenoterol-ipratropium bromide combination in comparison with salbutamol].
Ginesu F; Ortu AR; Schena GP; Deiola G; Polo F
Arch Monaldi; 1983; 38(5-6):241-54. PubMed ID: 6238579
[No Abstract] [Full Text] [Related]
5. [Use of aerosols in obstructive respiratory tract diseases. Clinical-pharmacological studies using fenoterol, salbutamol, ipratropium bromide and terbutaline].
Kaik G
Schweiz Med Wochenschr; 1977 Dec; 107(52):1948-57. PubMed ID: 145654
[TBL] [Abstract][Full Text] [Related]
6. [Fenoterol in the treatment of bronchial obstruction in chronic asthmatiform bronchitis].
Montanari S; Pasqua F; Gramiccioni E
Clin Ter; 1982 Jul; 102(2):131-8. PubMed ID: 6216039
[No Abstract] [Full Text] [Related]
7. [Comparison of the bronchodilator action of fenoterol and salbutamol by aerosol administration in patients with bronchial asthma].
Todisco T; Ansidei V; Miele N; Porcellati C; Sorbini CA
Minerva Med; 1975 Dec; 66(84):4535-45. PubMed ID: 1202407
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the efficacy of two new bronchodilators (salbutamol and fenoterol) in children.
Baran D; Yernault JC; Azama M; Englert M
Acta Paediatr Belg; 1977; 30(2):105-8. PubMed ID: 888690
[No Abstract] [Full Text] [Related]
9. Fenoterol versus salbutamol nebuliser solution in asthma.
Hockley B; Johnson NM
Eur J Respir Dis Suppl; 1983; 128 (Pt 2)():543-5. PubMed ID: 6352317
[No Abstract] [Full Text] [Related]
10. [Comparison of the bronchodilator action of salbutamol and orciprenaline by aerosol administration in patients with chronic bronchopneumopathy].
Sorbini CA; Todisco T; Boschetti E
Minerva Med; 1976 Mar; 67(16):1079-83. PubMed ID: 1264384
[No Abstract] [Full Text] [Related]
11. Comparative study of the bronchospasmolytic effect of fenoterol (0.2 mg) salbutamol (0.4 mg) as powder inhalations in 20 patients with reversible bronchial obstruction.
Maesen FP; Smeets JJ; Bernsen R; Cornelissen PJ
Respiration; 1984; 45(3):265-70. PubMed ID: 6379788
[TBL] [Abstract][Full Text] [Related]
12. Comparison between fenoterol and salbutamol in asthmatic patients.
Palma-Carlos AG; Barbosa MA
Allergol Immunopathol (Madr); 1977; 5(3):227-30. PubMed ID: 329664
[TBL] [Abstract][Full Text] [Related]
13. [Bronchodilating and antiallergic effects of fenoterol in antigen-induced bronchial obstruction. Comparison between metered aerosol and respirator solution (author's transl)].
Schultze-Werninghaus G; Gonsior E; Meier-Sydow J
Prax Klin Pneumol; 1978 Apr; 32(4):257-65. PubMed ID: 643798
[No Abstract] [Full Text] [Related]
14. [Multicenter clinical study on the delayed use of ipratropium-fenoterol in broncho-obstructive pathology].
Babich S; Bariffi F; Bisetti A; Carnimeo N; Cavalli A; Corda M; De Michele G; Girbino G; Mancini PA; Melica A
Arch Monaldi; 1983; 38(5-6):305-16. PubMed ID: 6238585
[No Abstract] [Full Text] [Related]
15. [Clinical study of a new bronchodilator molecule in pediatrics (Th 1165, Fenoterol-Berotec)].
Longo L; Patruno D; Tempesta A; Scaramuzzi O; Laudadio L
Minerva Pediatr; 1981 Aug; 33(16):831-4. PubMed ID: 7311945
[No Abstract] [Full Text] [Related]
16. [Berotek treatment of bronchial asthma in combination with ischemic heart disease].
Klusova EV; Semenovich NI; Polivanov EG; Pashkova TL
Sov Med; 1979 Apr; (4):48-51. PubMed ID: 375421
[No Abstract] [Full Text] [Related]
17. A comparison of the effects of salbutamol, fenoterol, and placebo aerosols on airway resistance in asthmatics.
Siddorn JA
Med J Zambia; 1976 Dec-1977 Jan; 10(6):153-6. PubMed ID: 14454
[No Abstract] [Full Text] [Related]
18. [Comparative study of the bronchodilating effect of SCH 1000, berotec and of the association of the two drugs in patients with spastic bronchitis (author's transl)].
Verstraeten JM
Acta Tuberc Pneumol Belg; 1974; 65(5):534-9. PubMed ID: 4282820
[No Abstract] [Full Text] [Related]
19. [Study of the ventilatory and cardiocirculatory effects of a beta-2-stimulating drug (salbutamol) in patients with the respiratory dysfunctional syndrome of the obstructive type].
Melillo G; D'Amato G; Cocco G
Minerva Med; 1976 Mar; 67(15):964-8. PubMed ID: 1264368
[No Abstract] [Full Text] [Related]
20. [New developments in the field of bronchospasmolytics].
Nolte D
Clin Ter; 1980 Jan; 92(1):3-13. PubMed ID: 7449306
[No Abstract] [Full Text] [Related]
[Next] [New Search]
